Search

everythinglearnresearchcommunity

for

Search:↓

A dog's hair loss was caused by a hormone-secreting testicular tumor.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

Hair transplant surgeons should also focus on their patients' overall health, including regular check-ups and screening for common health issues.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Dr. Yarborough denied endorsing Derma Genesis and was mistakenly represented due to his office manager's error; also, over 30% of tested skin products were contaminated with bacteria.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

Androgenetic alopecia is common, affects self-image, and has no complete cure yet.

Mutations in the AR gene cause hair thinning and loss.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Topical finasteride may help treat facial hirsutism in women.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Dutasteride reduces DHT more effectively than finasteride.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.